Temporary restraining order for Dr Reddy’s

By: |
New Delhi | June 17, 2018 3:00 AM

Pharma major Dr Reddy's Laboratories said on Saturday a US district court has issued a temporary restraining order on the sale and commercialisation of its generic Buprenorphine and Naloxone sublingual film in the American market.

Temporary restraining order for Pharma major Dr Reddy’s by US District court

Pharma major Dr Reddy’s Laboratories said on Saturday a US district court has issued a temporary restraining order on the sale and commercialisation of its generic Buprenorphine and Naloxone sublingual film in the American market.

It is indicated for treatment of opioid dependence. The firm said in a BSE filing the company remains confident in its legal positions on this patent. “The court order does not include a prohibition on commercial manufacturing of the product,” it added.

The company said, following the launch of its generic Buprenorphine and Naloxone sublingual film in the US market, “the US district court for New Jersey has received and reviewed an emergency application from the plaintiffs in the current patent litigation for a temporary restraining order and preliminary injunction against Dr Reddy’s”.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Consumer affairs min issues draft consumer protection e-Commerce rules 2020
2Modi govt proposes ban on mis-selling, fraudulent flash sales on e-commerce platforms; seeks public comments
3PlayStation 5, PlayStation 5 Digital Edition India pre-orders go live on June 23: Here’s where you can reserve a unit